Tumor necrosis factor-related apoptosis inducing ligand gene polymorphisms are correlated with gastric cancer in central China

Pharmaceutical Research

Volumn 32, Issue 3, 2015, Pages 762-768

  Wang, Changgao ^a   Xu, Shufang ^a   Yi, Fengming ^b   Wang, Xiaobing ^a   Lei, Yuan ^a,b   Huang, Sha ^b   Zhou, Rui ^a,b   Xia, Bing ^a,b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases   (China)

Author keywords

gastric cancer; genetic polymorphism; restriction fragment length polymorphism polymerase chain reaction; risk factors; tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADENOCARCINOMA; APOPTOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CELL DIFFERENTIATION; CHI SQUARE DISTRIBUTION; CHINA; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PHENOTYPE; RISK; RISK FACTOR; STOMACH TUMOR;

ADENOCARCINOMA; APOPTOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84887869311     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1217-y     Document Type: Article

References (23)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995;3:673-82.
2. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al. The receptor for the cytotoxic ligand TRAIL. Science. 1997;276:111-3.
3. Hu JK, Yang K, Li CM, Zhang B, Chen ZX, Chen XZ, et al. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells. Oncol Rep. 2009;21:681-8.
4. Li C, Xia B, Yang Y, Li J, Xia HH. TNF gene polymorphisms and helicobacter pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol. 2005;100:290-4.
5. Gray HL, Sorensen EL, Hunt JS, Ober C. Three polymorphisms in the 3' UTR of the TRAIL (TNF-related apoptosis-inducing ligand) gene. Genes Immunol. 2001;2:469-70.
6. Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, Miyazaki Y, Sasaki H. TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol. 2005;167:170-4.
7. Yan X, Xu L, Qi J, Liang X, Ma C, Guo C, et al. sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics. 2009;61:551-6.
8. Chen B, Liu S, Wang XL, Xu W, Li Y, Zhao WH, et al. TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis. Eur J Cancer. 2009;45:2598-605.
9. Fernàndez V, Jares P, Beà S, Salaverria I, Guino E, de Sanjosé S, et al. Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Haematologica. 2004;89:1322-31.
10. Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, et al. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res. 2001;7:1688-97.
11. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, et al. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene. 2001;20:399-403.
12. Frank B, Shanmugam KS, Beckmann L, Hemminki K, Brenner H, Hoffmeister M, et al. Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:2002-5.
13. Pal R, Gochhait S, Chattopadhyay S, Gupta P, Prakash N, Agarwal G, et al. Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor. Breast Cancer Res Treat. 2011;126:333-43.
14. Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, et al. Common genetic variants in candidate genes and risk of familial lymphoid malignancies. Br J Haematol. 2009;146:418-23.
15. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5:157-63.
16. Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol. 2002;168:1356-61.
17. Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Yamaguchi N, Yagita H, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell Immunol. 2001;214:194-200.
18. Holoch PA, Griffith TS. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur J Pharmacol. 2009;625:63-72.
19. Koyama S, Koike N, Adachi S. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol. 2002;128:73-9.
20. Martin JH, Potthoff A, Ledig S, Cornberg M, Jandl O, Manns MP, et al. Effect of H. Pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis. Helicobacter. 2004;9:371-86.
21. Weber A, Wandinger KP, Mueller W, Aktas O, Wengert O, Grundström E, et al. Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis. J Neuroimmunol. 2004;149:195-201.
22. Komatsuda A, Wakui H, Iwamoto K, Togashi M, Maki N, Masai R, et al. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus. Clin Immunol. 2007;125:26-9.
23. Koyama S. Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J Gastroenterol Hepatol. 2003;18:763-70.